2020
DOI: 10.1007/s11033-020-05334-5
|View full text |Cite
|
Sign up to set email alerts
|

Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
34
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(34 citation statements)
references
References 37 publications
0
34
0
Order By: Relevance
“…Besides, ERO1L significantly increased the Wnt/catenin pathway activity through regulating the downstream genes of Wnt/catenin including MYC, CD44, RUNX2, and SNAI1. [ 42 ] Previous studies have suggested that the serum metadherin mRNA and serum HtrA2 mRNA could be served as potential diagnosis biomarkers for colorectal cancer [ 43 ] and breast cancer, [ 44 ] respectively.…”
Section: Discussionmentioning
confidence: 99%
“…Besides, ERO1L significantly increased the Wnt/catenin pathway activity through regulating the downstream genes of Wnt/catenin including MYC, CD44, RUNX2, and SNAI1. [ 42 ] Previous studies have suggested that the serum metadherin mRNA and serum HtrA2 mRNA could be served as potential diagnosis biomarkers for colorectal cancer [ 43 ] and breast cancer, [ 44 ] respectively.…”
Section: Discussionmentioning
confidence: 99%
“…[ 5 ] Therefore, it is important to identify effective markers that could help in survival prognosis and could also be served as therapeutic targets. The recent advances [ 6 8 ] in prognostic markers provided important evidence of clinical use of those indicators. For patients with colorectal cancer (CRC), Metadherin mRNA expression is a useful non-invasive biomarker.…”
Section: Introductionmentioning
confidence: 99%
“…For patients with colorectal cancer (CRC), Metadherin mRNA expression is a useful non-invasive biomarker. [ 6 ] Metadherin mRNA expression is effective for screening and early diagnosis of CRC; and is correlated to advanced tumor stage and a poor prognosis. [ 6 ] Circulating high-temperature-required protein A2 (HtrA2) mRNA expression was reported as a significant diagnostic marker for breast cancer.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Most cancer types have some classic but limited biomarkers which cannot always meet clinical requirements. Therefore, increasing studies are focusing on finding new and effective tumor gene markers in various cancer types [ 1 – 3 ]. However, to meet more complex and more personalized clinical needs, tumor-related genes still need further and deeper exploitation.…”
Section: Introductionmentioning
confidence: 99%